DPP-4 Inhibitor Reduces Central Blood Pressure in a Diabetic and Hypertensive Patient: A Case Report

Hypertension and type 2 diabetes mellitus (DM) are among the main risk factors for the development of cardiovascular disease. Pharmacotherapy for DM should not only improve blood glucose control, but also provide beneficial glucose-independent cardiovascular effects. The central systolic blood press...

Descripción completa

Detalles Bibliográficos
Autores principales: Cosenso-Martin, Luciana Neves, Giollo-Junior, Luiz Tadeu, Vilela-Martin, José Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504643/
https://www.ncbi.nlm.nih.gov/pubmed/26166078
http://dx.doi.org/10.1097/MD.0000000000001068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504643/
https://www.ncbi.nlm.nih.gov/pubmed/26166078
http://dx.doi.org/10.1097/MD.0000000000001068

Ejemplares similares